The clinical relevance of CMKLR1 as a marker of lung inflammation in ARDS was confirmed using RNA sequencing data, which showed that CMKLR1 expression is significantly increased in lung monocytes and macrophages in COVID-19 patients. The gene discussed is CMKLR1; the disease is acute respiratory distress syndrome.